| __timestamp | Apellis Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 15635076 |
| Thursday, January 1, 2015 | 13730311 | 23943601 |
| Friday, January 1, 2016 | 22978599 | 23689111 |
| Sunday, January 1, 2017 | 40303878 | 41006114 |
| Monday, January 1, 2018 | 105285576 | 51379106 |
| Tuesday, January 1, 2019 | 220968770 | 32705593 |
| Wednesday, January 1, 2020 | 299921000 | 53274000 |
| Friday, January 1, 2021 | 420869000 | 85352000 |
| Saturday, January 1, 2022 | 387236000 | 51999000 |
| Sunday, January 1, 2023 | 354387000 | 59471000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Apellis Pharmaceuticals, Inc. and Summit Therapeutics Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to bring groundbreaking therapies to market.
From 2014 to 2023, Apellis Pharmaceuticals has consistently outpaced Summit Therapeutics in R&D spending, with an average annual investment nearly four times greater. In 2021, Apellis reached its peak, allocating over 420% more than its 2014 expenditure. Meanwhile, Summit's R&D spending has remained relatively stable, peaking in 2017 with a 160% increase from 2014.
This financial commitment underscores Apellis's aggressive strategy to lead in innovation, while Summit's steady approach reflects a more measured path. As the biotech landscape evolves, these investment trends will likely shape the future of medical breakthroughs.
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.